CatalystEarnings

$HALO (HALOZYME THERAPEUTICS) — 8-K: HALO Q2 FY26 EPS $2.28 smashes consensus by 31.8%

HALO

$109.19

+1.36%

What changed

Adjusted EPS of $2.28 beat consensus of $1.73 by $0.55 (+31.8%). Revenue was $481M. FY2026 guidance was reiterated with adjusted EPS of $8.65-$9.00 and revenue of $1.8B-$1.9B.

Why it matters

Adjusted EPS of $2.28 beat consensus of $1.73 by $0.55 (+31.8%). Revenue was $481M. FY2026 guidance was reiterated with adjusted EPS of $8.65-$9.00 and revenue of $1.8B-$1.9B.

Sources

sec